Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CCRN vs HDSN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
HDSN Captures Overall Composite Edge (53.2 HOLD vs 52.5 HOLD), While CCRN Leads 4–2 on Growth & Valuation Pillars
HDSN Overall Winner
6-Pillar Tally: CCRN 4 – 2 HDSN
Matrix Metrics: CCRN 4 – 6 HDSN
As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Cross Country Healthcare Inc (CCRN) on higher Unified Composite conviction (53.2/100 HOLD vs. 52.5/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while CCRN wins 4–2 across the 6-pillar growth and valuation breakdown. CCRN trades at $13.25 (47.3x Forward P/E, -0.8% operating margin) versus HDSN at $4.25 (25.9x Forward P/E, 2.0% operating margin).
- Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. CCRN 52.5/100 HOLD) and 1.32β · 68% Vol risk profile, whereas CCRN leads top-line expansion (-17.8% YoY revenue growth, 12.61x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: CCRN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 76.1); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About CCRN vs HDSN
CCRN
Cross Country Healthcare Inc
$13.25
+0.08% 1D
Market Cap
$427.7M
TTM Revenue
$1.00B
Forward P/E
47.3x
Beta / 30D Vol
0.50β · 2% Vol
Unified Composite Score
52.5
HOLD
Tech 40.0
Fund 50.0
Flow 69.0
Mom 40.0
Weinstein Technical Phase
Markup · Hold / add on dips
HDSN
Head-to-Head Winner
Hudson Technologies Inc
$4.25
-3.52% 1D
Market Cap
$186.5M
TTM Revenue
$242M
Forward P/E
25.9x
Beta / 30D Vol
1.32β · 68% Vol
Unified Composite Score
53.2
HOLD
Tech 67.0
Fund 65.0
Flow 55.0
Mom 70.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (CCRN 4 – 2 HDSN)
1. Valuation Multiples
HDSN
Forward P/E
47.3x
25.9x
Trailing P/E
126.6x
16.5x
PEG Ratio
12.61x
0.29x
EV / Revenue
0.3x
0.6x
2. Growth & Scale
CCRN
Revenue Growth (YoY)
-17.8%
-19.7%
Earnings Growth (YoY)
-78.5%
-82.0%
TTM Revenue (USD)
$1.00B
$242M
Market Cap
$427.7M
$186.5M
3. Profitability & Quality
HDSN
Gross Margin
20.2%
21.0%
Operating Margin
-0.8%
2.0%
Net Profit Margin
-9.8%
-0.5%
Return on Equity (ROE)
-27.0%
-0.5%
4. Balance Sheet & Cash Flow
CCRN
Cash Generation (TTM)
$40M
-$32M
Cash Flow Margin
4.0%
-13.0%
Net Cash / Leverage
$104M Net Cash
$31M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
CCRN
Options Structure Phase
UNCLASSIFIED
BREAKDOWN
Current IV / %ile
11.1% (4th %ile)
79.1% (15th %ile)
Put/Call OI Skew
0.76x (Call-Skewed)
N/A
OBV Trend / Tech Phase
NEUTRAL · Markup
ACCUMULATION · Markdown
6. R&D & Supply-Chain Moat
CCRN
OpEx & R&D Intensity
21.0% of Rev ($210M)
19.0% of Rev ($46M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Medical Care Facilities Operator
Specialty Chemicals Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: CCRN (4) vs HDSN (6)| Institutional Metric | CCRN | HDSN | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $427.7M | $186.5M | CCRN | |
| Trailing P/E Ratio | 126.6x | 16.5x | HDSN | |
| Forward P/E Ratio | 47.3x | 25.9x | HDSN | |
| Revenue Growth (YoY) | -17.8% | -19.7% | CCRN | |
| Operating Margin (TTM) | -0.8% | 2.0% | HDSN | |
| Net Profit Margin | -9.8% | -0.5% | HDSN | |
| Return on Equity (ROE) | -27.0% | -0.5% | HDSN | |
| 52-Week Range Position | 77% ($7–$15) | 6% ($4–$8) | CCRN | |
| Beta / 30D Volatility | 0.50β · 2% Vol | 1.32β · 68% Vol | CCRN | |
| Unified Institutional Score | 52.5 / 100 (HOLD) | 53.2 / 100 (HOLD) | HDSN | |
| Trailing 12M Revenue (USD) | $1.00B | $242M | Scale | |
| Gross Profit Margin (TTM) | 20.2% | 21.0% | Quality | |
| PEG Ratio & EV / Revenue | 12.61x PEG · 0.3x EV/Rev | 0.29x PEG · 0.6x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $40M ($104M Net Cash) | -$32M ($31M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
HDSN +7.92 pp
3M Horizon
CCRN +38.01 pp
6M Horizon
CCRN +63.09 pp
1Y Horizon
CCRN +32.83 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CCRN Revenue | HDSN Revenue | CCRN Op. Margin | HDSN Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $820M | $170M | -1.6% | -25.6% | CCRN |
| FY2019 | $820M | $160M | -1.9% | -9.7% | CCRN |
| FY2020 | $840M | $150M | -1.1% | 4.0% | HDSN |
| FY2021 | $1.68B | $190M | 8.3% | 21.9% | HDSN |
| FY2022 | $2.80B | $330M | 9.6% | 40.4% | HDSN |
| FY2023 | $2.02B | $290M | 5.6% | 27.0% | HDSN |
| FY2024 | $1.34B | $240M | -1.3% | 12.4% | HDSN |
| FY2025 | $1.05B | $250M | -8.0% | 7.5% | HDSN |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
CCRN
UNCLASSIFIED
Current IV
11.1%
IV Percentile
4th %ile
Put/Call OI Skew
0.76x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact CCRN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
HDSN
BREAKDOWN
Current IV
79.1%
IV Percentile
15th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
ACCUMULATION
Exact HDSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
CCRN Moat Profile
Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
OpEx & R&D Reinvestment
21.0% of Rev ($210M)
90D Engineering Disclosures
0 Published
HDSN Moat Profile
Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
OpEx & R&D Reinvestment
19.0% of Rev ($46M)
90D Engineering Disclosures
0 Published
Investor FAQ CCRN vs HDSN Key Questions & Quantitative Answers
As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Cross Country Healthcare Inc (CCRN) on higher Unified Composite conviction (53.2/100 HOLD vs. 52.5/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while CCRN wins 4–2 across the 6-pillar growth and valuation breakdown. CCRN trades at $13.25 (47.3x Forward P/E, -0.8% operating margin) versus HDSN at $4.25 (25.9x Forward P/E, 2.0% operating margin). Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. CCRN 52.5/100 HOLD) and 1.32β · 68% Vol risk profile, whereas CCRN leads top-line expansion (-17.8% YoY revenue growth, 12.61x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CCRN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 76.1); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CCRN leads the Growth & Scale pillar: CCRN posts -17.8% YoY revenue growth and -78.5% YoY earnings growth on $1.00B TTM revenue (20.2% gross margin, -0.8% operating margin), compared with HDSN at -19.7% YoY revenue growth and -82.0% YoY earnings growth on $242M TTM revenue (21.0% gross margin, 2.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CCRN cumulative revenue shifted +28.0% while HDSN shifted +47.1%. In operating R&D and SG&A reinvestment, CCRN deploys 21.0% of Rev ($210M) (0 90-day corporate R&D disclosures) versus 19.0% of Rev ($46M) (0 disclosures) for HDSN.
HDSN screens cheaper on headline valuation multiples. CCRN trades at 47.3x Forward P/E, 126.6x Trailing P/E, 12.61x PEG, and 0.3x EV/Revenue (4.0% FCF margin), whereas HDSN trades at 25.9x Forward P/E, 16.5x Trailing P/E, 0.29x PEG, and 0.6x EV/Revenue (-13.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CCRN (-27.0% ROE) versus HDSN (-0.5% ROE) capital efficiency.
In options market volatility and institutional positioning, CCRN carries 11.1% implied volatility (4th %ile, Compressed (<25th %ile)), a 0.76x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.50β · 2% Vol realized risk). By comparison, HDSN carries 79.1% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.32β · 68% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
HDSN vs CCRN · Reverse Pair
CCRN vs KELYA
· Sector Peer
CCRN vs KFRC
· Sector Peer
CCRN vs AMN
· Sector Peer
HDSN vs RCMT
· Sector Peer
HDSN vs HNRG
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem